In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer
Author:
Affiliation:
1. Department of Oncology, the Affiliated hospital of Southwest Medical University, Luzhou, China;
2. Department of Nuclear Medicine, the Affiliated hospital of Southwest Medical University, Luzhou, China
Funder
Health and Family Planning Commission of Sichuan Province
Office of Science & Technology and Intellectual Property of Luzhou
Union Project of Luzhou and Southwest Medical University
Publisher
Informa UK Limited
Subject
Pharmaceutical Science,General Medicine
Link
https://tandfonline.com/doi/pdf/10.1080/10717544.2017.1384862
Reference39 articles.
1. The Lessons of GIST—PET and PET/CT: A New Paradigm for Imaging
2. Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma
3. Is 18F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non–Small Cell Lung Cancer?
4. American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
5. Immunohistochemical evaluation of proliferative activity (Ki-67 index) in different histological types of cutaneous basal cell carcinoma
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Optimizing gefitinib nanoliposomes by Box-Behnken design and coating with chitosan: A sequential approach for enhanced drug delivery;ADMET and DMPK;2024-07-31
2. Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer;International Journal of Pharmaceutics;2024-01
3. Busting the Breast Cancer with AstraZeneca’s Gefitinib;Advances in Pharmacological and Pharmaceutical Sciences;2023-12-04
4. Drug delivery systems of gefitinib for improved cancer therapy: A review;OpenNano;2023-11
5. Antirheumatoid arthritis and cellular uptake study of cefuroxime axetil-loaded boswellic acids nanoparticles on RAW 264.7 cells;Future Journal of Pharmaceutical Sciences;2023-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3